Position in AMGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,708,831
+$161,130 QoQ
Shares Held
10,242
+1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#971
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $83,408,432 across 14 Drug Manufacturers - General names. AMGN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,150 | $24,168,514 | |
| 2 | JNJ |
Johnson & Johnson
|
66,025 | $16,768,367 | |
| 3 | ABBV |
AbbVie Inc.
|
42,284 | $10,640,343 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,463 | $6,741,493 | |
| 5 | NVS |
Novartis AG
|
29,508 | $4,624,493 | |
| 6 | AZN |
Astrazeneca PLC
|
20,071 | $3,805,862 | |
| 7 | AMGN |
Amgen Inc
This page
|
10,242 | $3,708,831 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,093 | $3,043,907 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,708,831 | 10,242 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $3,547,701 | 10,083 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $3,240,694 | 9,901 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,715,609 | 9,623 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,239,392 | 11,602 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $4,376,964 | 14,049 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $3,674,241 | 14,097 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $4,477,106 | 13,895 | Shares | Other | 2024-10-23 | |
| 2024-06-30 | $3,643,166 | 11,660 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,217,079 | 11,315 | Shares | Other | 2024-04-11 | |
| 2023-12-31 | $3,178,011 | 11,034 | Shares | Other | 2024-01-23 | |
| 2023-09-30 | $2,636,266 | 9,809 | Shares | Other | 2023-10-19 | |
| 2023-06-30 | $1,636,064 | 7,369 | Shares | Other | 2023-07-26 | |
| 2023-03-31 | $2,821,222 | 11,670 | Shares | Other | 2023-04-27 | |
| 2022-12-31 | $2,217,730 | 8,444 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $1,816,723 | 8,060 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $1,807,475 | 7,429 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $1,791,159 | 7,407 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,458,928 | 6,485 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,424,754 | 6,700 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,659,936 | 6,810 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,408,263 | 5,660 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $1,278,123 | 5,559 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,670,592 | 6,573 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,376,477 | 5,836 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $1,115,216 | 5,501 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||